Cross-sectional imaging in patients with primary sclerosing cholangitis: Single time-point liver or spleen volume is associated with survival. Issue 132 (November 2020)
- Record Type:
- Journal Article
- Title:
- Cross-sectional imaging in patients with primary sclerosing cholangitis: Single time-point liver or spleen volume is associated with survival. Issue 132 (November 2020)
- Main Title:
- Cross-sectional imaging in patients with primary sclerosing cholangitis: Single time-point liver or spleen volume is associated with survival
- Authors:
- Khoshpouri, Pegah
Ghadimi, Maryam
Rezvani Habibabadi, Roya
Motaghi, Mina
Venkatesh, Bharath Ambale
Shaghaghi, Mohammadreza
Pandey, Ankur
Hazhirkarzar, Bita
Ameli, Sanaz
Ghasabeh, Mounes Aliyari
Pandey, Pallavi
Kamel, Ihab R. - Abstract:
- Abstract: Aim: To evaluate the association between single time-point quantitative liver and spleen volumes in patients with PSC and transplant-free survival, independent of Mayo risk score. Materials and Methods: This HIPAA-compliant retrospective study included 165 PSC patients in a hospital. Total (T), and lobar (right [R], left [L], and caudate [C]) liver volumes and spleen volume (S) were measured. Adverse outcome was identified as being on liver transplantation list, transplantation or death (outcome 1), and transplantation or death (outcome 2). Cox-regression was performed to assess the predictive value of volumetric parameters to predict transplant-free survival with and without Mayo risk score. Stratified analysis by Mayo risk score categories was performed to assess the discriminative value of volumes in the model. Prediction models were developed dependent of Mayo score, based on patients demographics, lab values and volumetric measures for both defined outcomes. Kaplan-Meier curves were depicted for different liver and spleen volumes. P value <0.05 was considered statistically significant. Results: In this cohort (age 43 ± 17 years; 59 % men) 51 % of patients had adverse outcome. Cox-regression analysis demonstrated statistically significant association between values of T, L, R, C, S, L/T, and C/T and outcome 1; and also statistically significant association between values C, S, and C/T and outcome 2. Prediction models included age, INR, total bilirubin, AST,Abstract: Aim: To evaluate the association between single time-point quantitative liver and spleen volumes in patients with PSC and transplant-free survival, independent of Mayo risk score. Materials and Methods: This HIPAA-compliant retrospective study included 165 PSC patients in a hospital. Total (T), and lobar (right [R], left [L], and caudate [C]) liver volumes and spleen volume (S) were measured. Adverse outcome was identified as being on liver transplantation list, transplantation or death (outcome 1), and transplantation or death (outcome 2). Cox-regression was performed to assess the predictive value of volumetric parameters to predict transplant-free survival with and without Mayo risk score. Stratified analysis by Mayo risk score categories was performed to assess the discriminative value of volumes in the model. Prediction models were developed dependent of Mayo score, based on patients demographics, lab values and volumetric measures for both defined outcomes. Kaplan-Meier curves were depicted for different liver and spleen volumes. P value <0.05 was considered statistically significant. Results: In this cohort (age 43 ± 17 years; 59 % men) 51 % of patients had adverse outcome. Cox-regression analysis demonstrated statistically significant association between values of T, L, R, C, S, L/T, and C/T and outcome 1; and also statistically significant association between values C, S, and C/T and outcome 2. Prediction models included age, INR, total bilirubin, AST, variceal bleeding, S, and C for outcome 1 and age, INR, total bilirubin, AST, variceal bleeding, and S for outcome 2. Conclusions: Based on our observational study, quantitative liver and spleen volumes may be associated with transplant-free survival in patients with PSC and may have the potential for predicting the outcome but this should be validated by randomized clinical trial studies. … (more)
- Is Part Of:
- European journal of radiology. Issue 132(2020)
- Journal:
- European journal of radiology
- Issue:
- Issue 132(2020)
- Issue Display:
- Volume 132, Issue 132 (2020)
- Year:
- 2020
- Volume:
- 132
- Issue:
- 132
- Issue Sort Value:
- 2020-0132-0132-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11
- Subjects:
- Radiologic -- Surrogate marker -- Risk -- Liver transplantation
Medical radiology -- Periodicals
Radiology -- Periodicals
Radiologie médicale -- Périodiques
Medical radiology
Periodicals
616.075705 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0720048X ↗
http://www.elsevier.com/homepage/elecserv.htt ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0720048X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejrad.2020.109331 ↗
- Languages:
- English
- ISSNs:
- 0720-048X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.738050
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14743.xml